Pioneers of blood and tissue microbiome exploration, we are leaders in low bacterial biomass sample analysis

ABOUT VAIOMER
V de Voimer

Microbiome analysis for convincing data

Our contamination aware approach is crucial

By carefully controlling for contamination at every step of microbiome analysis, we provide reliable data that reflect the actual bacterial load of tissues rather than contaminants.

Mission

Vaiomer microbiome analysis stimulates the discovery

of new disease mechanisms, new biomarkers to contribute to personalized medecine, new pathways to identify novel therapeutic targets.

Microbiome analysis applications

Blood and tissue microbiota in health and diseases

Cardio - metabolic diseases

Liver diseases

Gastrointestinal disorders

Cancer

Neurodegenerative and mental disorders

COVID, HIV & infectious diseases

COVID, HIV & infectious diseases

Autoimmune and inflammatory diseases

Nutrition

Kidney diseases

Microbiome in early life

Vaiomer microbiome expertise

Exploring the circulating and tissue microbiomes

Beyond the human gut microbiome

The microbiota is not only located in the gut. It expands to every part of the body, ranging from very high to very low bacterial biomass. Learn more by travelling through our microbiome atlas.

Vaiomer tailor - made metagenomics

Challenging low bacterial biomass samples are now accessible thanks to our specifically optimized and contamination-aware metagenomic workflow. Discover our microbiome analysis services.

INNOVATORS’ EXPERIENCE

The early explorers of tissue microbiomes

Dowload our white paper

 

Learn about the gut, blood and tissue microbiota, the link between gut dysbiosis and tissue inflammation, and discover how these microbiota positively or negatively influence our physiology and can cause disease

 

News and views

VAIOMER Experts’ Highlights

The human tumor microenvironment is colonized by cancer type–specific bacteria and fungi
Several studies have shown the importance of the gut microbiota in cancer progression and treatment response. More

The human tumor microenvironment is colonized by cancer type–specific bacteria and fungi

> The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Nejman et al., 2020, Science.
> Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Narunsky-Haziza et al., 2022, Cell.

Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity
Immunotherapy has revolutionized the treatment of several cancers. However, it remains elusive why only some patients benefit from these treatments and why some patients experience immune-related adverse events (irAEs). More

Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity

> The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer. Naqash et al., 2021, Ann Transl Med.

FRANCE RELANCE